Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials, Inc., 76311 [2015-30811]
Download as PDF
<![CDATA[
76311
Federal Register / Vol. 80, No. 235 / Tuesday, December 8, 2015 / Notices
and BOEM. However, BSEE works
closely with BOEM to review the
regulatory reporting requirements and to
ensure there is no duplicative reporting.
For more information on BSEE and
BOEM individual reporting
requirements refer to 30 CFR 250 and
550 respectively.
Public Availability of Comments:
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Dated: November 19, 2015.
Robert W. Middleton,
Deputy Chief, Office of Offshore Regulatory
Programs.
[FR Doc. 2015–30883 Filed 12–7–15; 8:45 am]
BILLING CODE 4310–VH–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Pharmaceutical Materials, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before February 8, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/OD/D, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearing should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
Lhorne on DSK9F6TC42PROD with NOTICES
DATES:
VerDate Sep<11>2014
14:17 Dec 07, 2015
Jkt 238001
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on October
26, 2015, Johnson Matthey
Pharmaceutical Materials, Inc.,
Pharmaceutical Service, 25 Patton Road,
Devens, Massachusetts 01434 applied to
be registered as a bulk manufacturer of
the following basic classes controlled
substances:
Controlled substance
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Nabilone (7379) ............................
Hydrocodone (9193) .....................
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Schedule
II
II
II
II
II
II
II
The company plans to utilize this
facility to manufacture small quantities
of the listed controlled substances in
bulk and to conduct analytical testing in
support of the company’s primary
manufacturing facility in West Deptford,
New Jersey. The controlled substances
manufactured in bulk at this facility will
be distributed to its customers.
Dated: November 30, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
classes of controlled substances.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007). No comments or
objections were submitted for this
notice.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Cambrex Charles City to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the following basic classes
of controlled substances:
Controlled substance
4-Anilino-N-phenethyl-4-piperidine
(ANPP) (8333).
Phenylacetone (8501) ..................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Schedule
II
II
II
II
BILLING CODE 4410–09–P
The company plans to import the
listed controlled substances for internal
use, and to manufacture bulk
intermediates for sale to its customers.
DEPARTMENT OF JUSTICE
Dated: November 30, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2015–30811 Filed 12–7–15; 8:45 am]
Drug Enforcement Administration
[FR Doc. 2015–30813 Filed 12–7–15; 8:45 am]
BILLING CODE 4410–09–P
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Cambrex Charles City
ACTION:
Drug Enforcement Administration
Notice of registration.
Cambrex Charles City applied
to be registered as an importer of certain
basic classes of controlled substances.
The Drug Enforcement Administration
(DEA) grants Cambrex Charles City
registration as an importer of those
controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated August 21, 2015, and published in
the Federal Register on August 31,
2015, 80 FR 52510, Cambrex Charles
City, 1205 11th Street, Charles City,
Iowa 50616–3466 applied to be
registered as an importer of certain basic
SUMMARY:
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Cody Laboratories, Inc.
ACTION:
Notice of registration.
Cody Laboratories, Inc.
applied to be registered as an importer
of certain basic classes of controlled
substances. The Drug Enforcement
Administration (DEA) grants Cody
Laboratories, Inc. registration as an
importer of those controlled substances.
SUPPLEMENTARY INFORMATION:
SUMMARY:
E:\FR\FM\08DEN1.SGM
08DEN1
]]>Agencies
[Federal Register Volume 80, Number 235 (Tuesday, December 8, 2015)]
[Notices]
[Page 76311]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-30811]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Johnson
Matthey Pharmaceutical Materials, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before February 8, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/OD/D,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearing should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
October 26, 2015, Johnson Matthey Pharmaceutical Materials, Inc.,
Pharmaceutical Service, 25 Patton Road, Devens, Massachusetts 01434
applied to be registered as a bulk manufacturer of the following basic
classes controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Nabilone (7379)............................ II
Hydrocodone (9193)......................... II
Alfentanil (9737).......................... II
Remifentanil (9739)........................ II
Sufentanil (9740).......................... II
------------------------------------------------------------------------
The company plans to utilize this facility to manufacture small
quantities of the listed controlled substances in bulk and to conduct
analytical testing in support of the company's primary manufacturing
facility in West Deptford, New Jersey. The controlled substances
manufactured in bulk at this facility will be distributed to its
customers.
Dated: November 30, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2015-30811 Filed 12-7-15; 8:45 am]
BILLING CODE 4410-09-P
